Cargando…
High-level inhibition of mitochondrial complexes III and IV is required to increase glutamate release from the nerve terminal
BACKGROUND: The activities of mitochondrial complex III (ubiquinol-cytochrome c reductase, EC 1.10.2.2) and complex IV (cytochrome c oxidase EC 1.9.3.1) are reduced by 30-70% in Huntington's disease and Alzheimer's disease, respectively, and are associated with excitotoxic cell death in th...
Autores principales: | Kilbride, Seán M, Gluchowska, Sonia A, Telford, Jayne E, O'Sullivan, Catherine, Davey, Gavin P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169489/ https://www.ncbi.nlm.nih.gov/pubmed/21791084 http://dx.doi.org/10.1186/1750-1326-6-53 |
Ejemplares similares
-
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals
por: Lin, Tzu-Yu, et al.
Publicado: (2015) -
Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex
por: Lin, Tzu-Yu, et al.
Publicado: (2013) -
Inhibition of Glutamate Release from Rat Cortical Nerve Terminals by Dehydrocorydaline, an Alkaloid from Corydalis yanhusuo
por: Lin, Tzu-Yu, et al.
Publicado: (2022) -
Non-genomic Actions of Methylprednisolone Differentially Influence GABA and Glutamate Release From Isolated Nerve Terminals of the Rat Hippocampus
por: Neiva, Rafael, et al.
Publicado: (2020) -
A Pair of Cobalt(III/IV) Terminal Imido Complexes
por: Mao, Weiqing, et al.
Publicado: (2021)